首页> 外国专利> Single monoclonal antibodies, preferably cell-related polyurethane CA 125/O772P binding, involve polyurethane CA125/O772P solubility; isobredol; nucleic acid, coding; pharmacological synthesis; polyurethane; and polyurethane for the production of T drugs. 1. Treatment of diffusive cell disorders (solar division). (No. 2086-03).

Single monoclonal antibodies, preferably cell-related polyurethane CA 125/O772P binding, involve polyurethane CA125/O772P solubility; isobredol; nucleic acid, coding; pharmacological synthesis; polyurethane; and polyurethane for the production of T drugs. 1. Treatment of diffusive cell disorders (solar division). (No. 2086-03).

机译：单个单克隆抗体，优选与细胞相关的聚氨酯CA 125 / O772P结合，涉及聚氨酯CA125 / O772P的溶解性;异丁醇核酸，编码;药理合成聚氨酯以及用于生产T药的聚氨酯。 1.弥漫性细胞疾病（太阳能分裂）的治疗。（第2086-03号）。

页面导航

摘要
著录项
相似文献

摘要

Isolated Monoclonal Antibodies that preferentially bind to the polypeptide CA 125 / o772p Associated cells on the polypeptide CA 125 / o772p spilled; hybridoma; Nucleic Acid encodes;Pharmaceutical Composition and its use for relieving symptoms of a disorder associated with CA 125 / o772p (div.sol.no.2086-03).

机译：优先与多肽CA 125 / o772p结合的分离的单克隆抗体洒落在多肽CA 125 / o772p上的相关细胞;杂交瘤核酸编码;药物组合物及其在减轻与CA 125 / o772p有关的疾病症状中的用途（解决方案编号2086-03）。

著录项

公开/公告号CL2010001209A1

专利类型
公开/公告日2011-04-01

原文格式PDF
申请/专利权人 PURDUE PHARMA L.P.;
展开▼

申请/专利号CL20100001209
发明设计人 EARL F. ALBONE;DANIEL A. SOLTIS;
展开▼

申请日2010-11-08
分类号A61K39/395;A61P35/00;C07H21/04;C07K16/30;C12N5/12;G01N33/53;
国家 CL
入库时间 2022-08-21 18:06:57

相似文献

专利